Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Licensing opportunity from NIH: method of refolding recombinant endostatin

June 20, 2000

Novel Roche compounds for MMP-related diseases

June 19, 2000

SUNY researchers discover inhibitors of PDC activity, describe use as anticancer agents

June 16, 2000

Xeloda approved in New Zealand as treatment for colorectal cancer

June 16, 2000

IDM signs cancer vaccine agreement with Sanofi-Synthelabo

June 16, 2000

Synthesis, activity and use of new inhibitors of protein farnesyltransferase

June 15, 2000

Fungally produced compound active against human tumor cell lines

June 15, 2000

Ligand receives approvable letter from FDA for Targretin Gel

June 15, 2000

Agouron and PPD Discovery create anticancer genomics alliance

June 15, 2000

AVI BioPharma demonstrates promise of new telomerase inhibitor

June 15, 2000

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...